Literature DB >> 22167403

Pulmonary coccidioidomycosis.

George R Thompson1.   

Abstract

Coccidioidomycosis refers to the spectrum of disease caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii. Clinical manifestations vary depending upon both the extent of infection and the immune status of the host. Coccidioidomycosis has been reported to involve almost all organ systems; however, pulmonary disease is the most common clinical manifestation. The incidence of coccidioidomycosis continues to rise, and primary coccidioidal pneumonia accounts for 17 to 29% of all cases of community-acquired pneumonia in endemic regions. The majority of patients with coccidioidomycosis resolve their initial infection without sequelae; however, several patients develop complications of disease ranging in severity from complicated pulmonary coccidioidomycosis to widely disseminated disease with immediately life-threatening manifestations. This review focuses on complications of pulmonary coccidioidomycosis with an emphasis on the management of primary coccidioidal infection, solitary pulmonary nodules, pleural effusions, cavitary disease, acute respiratory distress syndrome (ARDS), miliary disease, and sepsis. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167403     DOI: 10.1055/s-0031-1295723

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  27 in total

Review 1.  Surgical management of non-mycobacterial fungal infections.

Authors:  Staci Beamer
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

Authors:  George R Thompson; David A Stevens; Karl V Clemons; Josh Fierer; Royce H Johnson; Jane Sykes; George Rutherford; Michael Peterson; John W Taylor; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2014-10-16       Impact factor: 2.574

Review 4.  Pneumonia. Treatment and diagnosis.

Authors:  Joshua T Mattila; Michael J Fine; Andrew H Limper; Patrick R Murray; Bill B Chen; Philana Ling Lin
Journal:  Ann Am Thorac Soc       Date:  2014-08

5.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

6.  The coccidioidomycosis conundrum: a rare parotid mass.

Authors:  Christopher G Tang; Brian A Nuyen; Balaram Puligandla; Barry Rasgon
Journal:  Perm J       Date:  2014

7.  Coccidioidomycosis with diffuse miliary pneumonia.

Authors:  David Sotello; Marcella Rivas; Audra Fuller; Tashfeen Mahmood; Menfil Orellana-Barrios; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

8.  Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection.

Authors:  George R Thompson; Derek Bays; Sandra L Taylor; Stuart H Cohen; Demosthenes Pappagianis
Journal:  Med Mycol       Date:  2012-06-11       Impact factor: 4.076

9.  Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.

Authors:  George R Thompson; Janis E Blair; Sharon Wang; Robert Bercovitch; Michael Bolaris; Dane Van Den Akker; Rodrigo Lopez; Arash Heidari; Antonino Catanzaro; Jose Cadena; Peter Chin-Hong; Brad Spellberg; Royce Johnson
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

Review 10.  Diffuse cystic lung diseases.

Authors:  Jay H Ryu; Xinlun Tian; Misbah Baqir; Kaifeng Xu
Journal:  Front Med       Date:  2013-05-11       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.